Stock PTGX PROTAGONIST THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart Protagonist Therapeutics, Inc.

Equities

PTGX

US74366E1029

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-08 pm EDT 		5-day change 1st Jan Change
27.11 USD +5.12% Intraday chart for Protagonist Therapeutics, Inc. +6.06% +18.23%
May. 07 Protagonist Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 03 Protagonist Therapeutics Insider Sold Shares Worth $707,750, According to a Recent SEC Filing MT

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
PROTAGONIST THERAPEUTICS, INC.
Other Biotechnology & Medical Research
+5.12%+6.06%+18.23%+8.74%+184.17% 1.51B
Bearish
Bullish
Bullish
  1. Stock Market
  2. Equities
  3. PTGX Stock
  4. Charts Protagonist Therapeutics, Inc.
  5. Relative Strength Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW